Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design

• Үндсэн зохиолчид: Richard K. Zimmerman (Зохиогч), Klancie Dauer (Зохиогч), Lloyd Clarke (Зохиогч), Mary Patricia Nowalk (Зохиогч), Jonathan M. Raviotta (Зохиогч), G. K. Balasubramani (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Newer influenza vaccine formulations have entered the market, but real-world effectiveness studies are not widely conducted until there is sufficient uptake. We conducted a retrospective test-negative case-control study to determine relative vaccine effectiveness (rVE) of recombinant influenza vacci...